Investor Relations

OPKO Announces Second Quarter Operating and Financial Results more »

Rayaldee Phase 3 Trial Meets Primary Endpoints more »

OPKO Submits IND for Rayaldee™ as Adjunctive Cancer Therapy more »

OPKO to Announce Top Line RAYALDEE Results and Second Quarter 2014 Financial Results on August 11, 2014 more »

Corporate Governance

The Board of Directors of OPKO Health, Inc. (the "Company") sets high standards for the Company's employees, officers, and directors. Implicit in this philosophy is the importance of sound corporate governance. It is the duty of the Board of Directors to serve as a prudent fiduciary for shareholders and to oversee the management of the Company's business.

Communications with the Board

Stockholders and all interested parties may initiate in writing any communication with our Board of Directors, the presiding member of the non-management directors, or any individual director by sending the correspondence to OPKO Health, Inc., 4400 Biscayne Blvd., Miami, Florida 33137, Attention: Secretary. This centralized process assists our Board of Directors in reviewing and responding to communications in an appropriate manner. If a stockholder or any interested party would like the letter to be forwarded directly to one of the Chairmen of the three standing committees of the Board, he or she should so indicate. If no specific direction is indicated, the Secretary's office will review the letter and forward it to the appropriate Board member(s).


OPKO Management and Board of Directors
» Board of Directors
» Management Team

Document View
Audit Committee Charter   PDF   39.3 KB  
Compensation Committee Charter   PDF   47.5 KB  
Governance and Nominating Committee Charter   PDF   42.4 KB  
Code of Business Conduct and Ethics HTML PDF   48.6 KB  
Corporate Governance Guidelines   PDF   28.0 KB  
Conflict Minerals Policy   PDF  158.8 KB  
Specialized Disclosure Report - Form SD   PDF   59.6 KB